![[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]](https://image.slidesharecdn.com/swinefluupdateanindianprespective-090814043323-phpapp01/85/Swineflu-Update-An-Indian-Prespective-1-320.jpg)
![What do we do? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
Empfohlen
Weitere ähnliche Inhalte
Was ist angesagt?
Was ist angesagt? (20)
Andere mochten auch
Andere mochten auch (20)
Ähnlich wie Swineflu Update, An Indian Prespective
Ähnlich wie Swineflu Update, An Indian Prespective (20)
Mehr von chandra talur
Mehr von chandra talur (9)
Kürzlich hochgeladen
Kürzlich hochgeladen (20)
Swineflu Update, An Indian Prespective
- 10. TYPES
- 11. PIG THE CREATOR
- 16. Emergency hospital, Camp Funston, Kansas 1918
- 21. Global pandemic
- 23. Transmission
- 36. COMPARISION SEASONAL INFLUENZA H1N1 INFLUENZA AGE <5 YRS >60 YRS YOUNG & MIDDLE AGE SEVERITY LESS SEVERE PNEUMONIA ARDS MORBIDITY LESS MORE BUT >60 YRS LESS LIKELY TO HAVE SEVERE PNEUMONIA
- 37. contd SEASONAL INFLUENZA H1N1 INFLUENZA SYMPTOMS RESPIRATORY RESPIRATORY & GASTROINTESTINAL SECONDARY ATTACK RATE 5-15 % 22-33 % VACCINE PROTECTIVE UNDER DEVELOPMENT
- 42. DIAGNOSTIC TESTS RT PCR QUIDEL CULTURE DFA/IFA
- 47. CLINICAL FEATURES Vomiting or diarrhea (not typical for influenza but reported by recent cases of swine influenza infection)
- 48. Mexican data in MV patients
- 49. Mexican data in MV patients
- 50. Younger people at risk
- 51. 10-50 yrs Severe Respiratory Disease Concurrent with the Circulation of H1N1 Influenza Gerardo Chowell, Ph.D., Stefano M. Bertozzi, M.D., Ph.D., NEJM August 2009
- 63. H1 N1 Pneumonia
- 70. Tamiflu
- 71. Tamiflu
- 80. prevention
- 82. N95 Mask
- 87. Is Negative Pressure Room Must ? Place patients in a single-patient room with the door kept closed & droplet and contact isolation
- 88. Is BIA ready?
- 89. Why do we need vaccine COST EFFECTIVE TARGET AT RISK PEOPLE VACCINE WINTER SEASON TO COME(LOW HUMIDITY,TEMP) RAPID GLOBAL SPREAD SEASONAL VACCINE PROTECTION?
- 92. THANK YOU Department of critical care medicine